Latest Transformation News

MotorCycle Holdings Limited delivered a standout FY2025 with double-digit revenue and profit growth, underpinned by strong market share gains and operational efficiencies.

MotorCycle Holdings Limited reported a robust 2025 financial year with record revenue and profit growth, strengthened by key acquisitions that expanded its market share to 22%. The company’s focus on operational efficiency and digital transformation sets the stage for continued momentum in 2026.

Adherium Limited has reached a pivotal commercial milestone by expanding its Remote Patient Monitoring program across 110 U.S. Allergy Partners clinics, activating nearly 70% of the network and onboarding close to 700 patients in six months.

Maggie Beer Holdings reveals strategic progress in its 2025 AGM, focusing on operational simplification, financial stability, and targeted growth for its iconic brands.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.

Hancock & Gore is rebranding as Schoolblazer Limited following its acquisition of Trutex, consolidating its global school uniform operations and targeting over $200 million in revenue by FY27.

Hancock & Gore reports a statutory loss for FY25 amid major acquisitions and strategic transformation, setting sights on $200m revenue by FY27 as it rebrands to Schoolblazer Limited.

Recce Pharmaceuticals has reported compelling preclinical results for its inhaled anti-infective RECCE 327, demonstrating potent activity against multidrug-resistant pneumonia bacteria in mice models.

Sky Metals is fast-tracking its drilling program at the Tallebung Tin Project by mobilising a second rig to test high-grade silver-tin zones and expand its resource base. Early assay results are expected in December, setting the stage for an updated Mineral Resource Estimate next year.

Invictus Energy updates progress on its AMOG joint venture with Al Mansour Holdings, revealing ongoing negotiations for a significant Qatari ownership stake and deferral of a key placement settlement.

Enlitic has expanded its collaboration with GE Healthcare, adding around US$1 million in revenue and broadening the use of its medical imaging data solutions. This move underscores growing trust and integration between the two companies.

Patrys Limited has expanded its clinical pipeline by acquiring Reliis Pty Ltd, gaining a proprietary injectable formulation of Quetiapine aimed at the large and underserved delirium market. This strategic move balances Patrys’ portfolio with a near-term pharmaceutical asset alongside its biologics program.